DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Keppra (Levetiracetam) - Foetal Exposure During Pregnancy - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Foetal Exposure During Pregnancy (96)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Keppra (Levetiracetam) where reactions include foetal exposure during pregnancy. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 96   Next >>

Possible Keppra side effects in 21 month old female

Reported by a physician from United States on 2012-08-24

Patient: 21 month old female

Reactions: Foetal Exposure During Pregnancy, Febrile Convulsion

Drug(s) suspected as cause:
Keppra



Possible Keppra side effects in male

Reported by a physician from United States on 2012-08-22

Patient: male

Reactions: Psychomotor Hyperactivity, Speech Disorder Developmental, Exposure During Breast Feeding, Restlessness, Foetal Exposure During Pregnancy, Abnormal Behaviour, Constipation, Aggression, Poor Quality Sleep, Choking, Coordination Abnormal

Drug(s) suspected as cause:
Keppra
    Indication: Epilepsy
    End date: 2009-02-03

Keppra XR
    Start date: 2009-02-03

Keppra XR
    Indication: Epilepsy
    Start date: 2009-02-03
    End date: 2009-07-16



Possible Keppra side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-09

Patient: male

Reactions: Foetal Exposure During Pregnancy, Exomphalos

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Keppra
    Dosage: 2000mg twice per day
    Indication: Convulsion
    End date: 2009-05-29

Lamictal
    Indication: Convulsion
    End date: 2009-05-29

Other drugs received by patient: Multi-Vitamin; Zyrtec



Possible Keppra side effects in

Reported by a physician from France on 2012-08-03

Patient:

Reactions: Clubbing, Retrognathia, Congenital Renal Cyst, Multiple Congenital Abnormalities, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Depakene
    Dosage: 500mg twice per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-11
    End date: 2012-02-01

Keppra
    Dosage: 250mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-01
    End date: 2012-04-06

Lamictal
    Dosage: 25mg twice per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-01
    End date: 2012-04-06



Possible Keppra side effects in male

Reported by a physician from Germany on 2012-08-01

Patient: male

Reactions: Dandy-Walker Syndrome, Premature Baby, Congenital Central Nervous System Anomaly, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Keppra



Possible Keppra side effects in male

Reported by a physician from United States on 2012-07-31

Patient: male, weighing 3.9 kg (8.6 pounds)

Reactions: Foetal Exposure During Pregnancy, Exomphalos

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Keppra

Other drugs received by patient: Lamotrigine; Lamotrigine; Multi-Vitamin; Zyrtec



Possible Keppra side effects in male

Reported by a consumer/non-health professional from Denmark on 2012-07-27

Patient: male

Reactions: Foot Deformity, Foetal Exposure During Pregnancy, Gait Disturbance

Drug(s) suspected as cause:
Keppra



Possible Keppra side effects in female

Reported by a physician from France on 2012-07-27

Patient: female, weighing 2.5 kg (5.5 pounds)

Reactions: Foetal Growth Restriction, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Keppra
    Indication: Epilepsy

Tegretol
    Indication: Epilepsy

Other drugs received by patient: Folic Acid



Possible Keppra side effects in female

Reported by a physician from United States on 2012-07-25

Patient: female, weighing 3.1 kg (6.9 pounds)

Reactions: Foetal Exposure During Pregnancy, Pleural Effusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Keppra
    Indication: Epilepsy

Keppra XR
    Indication: Epilepsy
    End date: 2009-06-15

Lacosamide
    Indication: Epilepsy
    Start date: 2009-06-15
    End date: 2010-06-22

Other drugs received by patient: Claritin; Lantus; Repliva; Glyburide; Advair Diskus 100 / 50; Albuterol; Multi-Vitamins



Possible Keppra side effects in male

Reported by a physician from Denmark on 2012-07-23

Patient: male

Reactions: Foot Deformity, Foetal Exposure During Pregnancy, Gait Disturbance

Drug(s) suspected as cause:
Keppra



Possible Keppra side effects in 6 month old male

Reported by a physician from United States on 2012-07-12

Patient: 6 month old male

Reactions: Tuberous Sclerosis, Developmental Delay, Foetal Exposure During Pregnancy, Convulsion

Drug(s) suspected as cause:
Keppra

Other drugs received by patient: Folic Acid



Possible Keppra side effects in female

Reported by a physician from United States on 2012-07-02

Patient: female, weighing 3.1 kg (6.8 pounds)

Reactions: Jaundice, Bradycardia Foetal, Foetal Exposure During Pregnancy, Haemangioma

Drug(s) suspected as cause:
Keppra
    Dosage: 1000 daily dose
    Indication: Epilepsy
    End date: 2009-11-01

Keppra XR
    Start date: 2009-11-01
    End date: 2010-05-31

Other drugs received by patient: Folic Acid; Multi-Vitamins; Ferrous Sulfate TAB



Possible Keppra side effects in 12 month old male

Reported by a physician from United States on 2012-06-21

Patient: 12 month old male, weighing 7.8 kg (17.2 pounds)

Reactions: Fine Motor Delay, Speech Disorder Developmental, Foetal Exposure During Pregnancy, Growth Retardation, Developmental Delay, Conjunctival Cyst, Gastrooesophageal Reflux Disease, Strabismus Congenital, Amblyopia

Drug(s) suspected as cause:
Keppra
    End date: 2008-09-05

Keppra
    Start date: 2008-09-06

Keppra
    Indication: Epilepsy
    Start date: 2005-01-01



Possible Keppra side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-20

Patient: female

Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy, Congenital Teratoma

Adverse event resulted in: death

Drug(s) suspected as cause:
Clobazam
    Dosage: 5 mg in the morning and 10 mg in the evening
    Start date: 2009-02-01
    End date: 2009-03-01

Clobazam
    Start date: 2009-03-01
    End date: 2009-03-31

Clobazam
    End date: 2009-02-01

Depakene
    End date: 2009-03-31

Keppra
    End date: 2009-03-01

Keppra
    Start date: 2009-03-01
    End date: 2009-03-31



Possible Keppra side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-20

Patient: male, weighing 0.9 kg (1.9 pounds)

Reactions: Premature Baby, Foetal Exposure During Pregnancy, Drug Withdrawal Syndrome Neonatal, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Keppra
    Indication: Foetal Exposure During Pregnancy
    End date: 2012-03-11

Nitrazepam
    Indication: Foetal Exposure During Pregnancy
    End date: 2012-03-11

Tegretol
    Indication: Foetal Exposure During Pregnancy
    End date: 2012-03-11

Topiramate
    Indication: Foetal Exposure During Pregnancy
    End date: 2012-03-11



Possible Keppra side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-19

Patient: male, weighing 0.9 kg (1.9 pounds)

Reactions: Blood Pressure Increased, LOW Birth Weight Baby, Agitation, Metabolic Acidosis, Premature Baby, Foetal Exposure During Pregnancy, Drug Withdrawal Syndrome Neonatal, Respiratory Distress, Tremor, C-Reactive Protein Increased, Pneumatosis, Hypotonia, Cryptorchism

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Keppra
    Dosage: maternal dose: 5 df, daily

Nitrazepam
    Dosage: maternal dose: 25 mg, qd

Tegretol
    Dosage: maternal dose: 400 mg, bid

Topiramate
    Dosage: maternal dose: 100 mg, bid



Possible Keppra side effects in male

Reported by a physician from France on 2012-06-19

Patient: male, weighing 6.9 kg (15.1 pounds)

Reactions: LOW Birth Weight Baby, Fallot's Tetralogy, Foetal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Keppra



Possible Keppra side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-15

Patient: male, weighing 0.9 kg (1.9 pounds)

Reactions: Blood Pressure Increased, Metabolic Acidosis, Pneumatosis, Premature Baby, Foetal Heart Rate Deceleration, Hypotonia, Foetal Exposure During Pregnancy, Drug Withdrawal Syndrome Neonatal, Tachycardia Foetal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Keppra
    End date: 2012-03-11

Nitrazepam
    Dosage: daily dose:25 mg
    End date: 2012-03-11

Tegretol
    End date: 2012-03-11

Topiramate
    End date: 2012-03-11

Other drugs received by patient: Catapres



Possible Keppra side effects in female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-06-08

Patient: female, weighing 2.2 kg (4.8 pounds)

Reactions: LOW Birth Weight Baby, Neonatal Respiratory Distress Syndrome, Premature Baby, Foetal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Keppra



Possible Keppra side effects in male

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-06-08

Patient: male, weighing 2.4 kg (5.3 pounds)

Reactions: LOW Birth Weight Baby, Neonatal Respiratory Distress Syndrome, Premature Baby, Foetal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Keppra



Possible Keppra side effects in 12 month old female

Reported by a physician from United States on 2012-05-15

Patient: 12 month old female

Reactions: Foot Deformity, Foetal Exposure During Pregnancy, Eyelid Ptosis Congenital

Drug(s) suspected as cause:
Keppra

Other drugs received by patient: Pneumococcal Conjugate Vaccine; Pneumococcal Conjugate Vaccine; Varicella-Zoster Immune Globulin (Human); Lamictal; Pneumococcal Conjugate Vaccine; Folic Acid; Lamictal; Pneumococcal Conjugate Vaccine; Vitamin and Mineral Prenatal Supplement W / Folic Acid CAP



Possible Keppra side effects in 1 month old male

Reported by a physician from United States on 2012-05-11

Patient: 1 month old male

Reactions: Foetal Exposure During Pregnancy, Hernia

Drug(s) suspected as cause:
Keppra
    End date: 2011-03-01

Keppra
    Indication: Epilepsy
    Start date: 2011-03-01
    End date: 2011-06-25

Levetiracetam
    Indication: Epilepsy
    Start date: 2011-06-25
    End date: 2011-07-31

Oxcarbazepine
    Indication: Epilepsy



Possible Keppra side effects in male

Reported by a physician from United States on 2012-05-09

Patient: male, weighing 11.8 kg (26.0 pounds)

Reactions: Speech Disorder, Exposure During Breast Feeding, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Keppra

Keppra

Other drugs received by patient: Multi-Vitamins; Multi-Vitamins; Folic Acid; Folic Acid



Possible Keppra side effects in male

Reported by a consumer/non-health professional from Germany on 2012-04-30

Patient: male, weighing 1.0 kg (2.2 pounds)

Reactions: Pneumonia, Hyperbilirubinaemia, Renal Impairment Neonatal, Premature Baby, Anaemia, Foetal Exposure During Pregnancy, Respiratory Distress, Renal Aplasia, Patent Ductus Arteriosus, Feeding Disorder, Bradycardia, Congenital Cystic Kidney Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Keppra

Other drugs received by patient: Ampicillin and Sulbactam; Folio Forte; Fungizid -Ratiopharm Vaginaltabletten



Possible Keppra side effects in female

Reported by a physician from Germany on 2012-04-30

Patient: female

Reactions: Cleft LIP and Palate, Spina Bifida, Foetal Exposure During Pregnancy, Heart Disease Congenital, Congenital Foot Malformation, Spine Malformation

Adverse event resulted in: death

Drug(s) suspected as cause:
Keppra

Other drugs received by patient: Folio Forte



Possible Keppra side effects in female

Reported by a physician from Netherlands on 2012-04-24

Patient: female

Reactions: Hypoventilation, Foetal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Keppra
    Dosage: 500-250-250
    Indication: Epilepsy
    Start date: 2011-01-01
    End date: 2012-03-30

Lamotrgine
    Indication: Epilepsy
    Start date: 2011-01-01
    End date: 2012-03-30

Other drugs received by patient: Ferrofumaraat; Vitamin K TAB; Foliumzuur; Fytomenadion



Possible Keppra side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-24

Patient:

Reactions: Congenital Anomaly, Foetal Exposure During Pregnancy, Volvulus of Small Bowel

Adverse event resulted in: death

Drug(s) suspected as cause:
Keppra



Possible Keppra side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-24

Patient: female, weighing 2.3 kg (5.0 pounds)

Reactions: Hypoplastic Left Heart Syndrome, Premature Baby, LOW SET Ears, Foetal Exposure During Pregnancy, Congenital Knee Dislocation

Drug(s) suspected as cause:
Keppra
    Indication: Epilepsy
    End date: 2010-08-01

Valproic Acid
    Dosage: 300 -150 - 300 (750 mg/day)
    Indication: Epilepsy
    End date: 2010-08-01



Possible Keppra side effects in 12 month old female

Reported by a physician from United States on 2012-04-18

Patient: 12 month old female

Reactions: Foot Deformity, Foetal Exposure During Pregnancy, Eyelid Ptosis Congenital

Drug(s) suspected as cause:
Keppra

Other drugs received by patient: Vitamin and Mineral Prenatal Supplement W / Folic Acid CAP; Lamictal; Lamictal; Pneumococcal Conjugate Vaccine; Folic Acid; Pneumococcal Conjugate Vaccine; Varicella-Zoster Immune Globulin (Human); Pneumococcal Conjugate Vaccine; Pneumococcal Conjugate Vaccine



Possible Keppra side effects in female

Reported by a physician from Netherlands on 2012-04-16

Patient: female, weighing 3.0 kg (6.6 pounds)

Reactions: Hypoventilation, Foetal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Keppra
    Indication: Epilepsy

Lamotrgine
    Dosage: 50mg three times per day
    Indication: Epilepsy

Other drugs received by patient: Folic Acid; Fytomenadion; Ferrous Fumarate



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017